CVS Health Corporation (BVL:CVS)

CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of PEN 331.64 billion. The enterprise value is 572.49 billion.

Market Cap	331.64B
Enterprise Value	572.49B

Important Dates

The next estimated earnings date is Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	Jul 22, 2025

Share Statistics

Current Share Class	1.27B
Shares Outstanding	n/a
Shares Change (YoY)	-1.02%
Shares Change (QoQ)	+0.47%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.27B

Valuation Ratios

The trailing PE ratio is 20.68 and the forward PE ratio is 11.13.

PE Ratio	20.68
Forward PE	11.13
PS Ratio	0.24
PB Ratio	1.21
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.64, with an EV/FCF ratio of 33.83.

EV / Earnings	35.69
EV / Sales	0.43
EV / EBITDA	9.64
EV / EBIT	17.49
EV / FCF	33.83

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 1.07.

Current Ratio	0.80
Quick Ratio	0.58
Debt / Equity	1.07
Debt / EBITDA	4.88
Debt / FCF	17.31
Interest Coverage	3.05

Financial Efficiency

Return on equity (ROE) is 5.88% and return on invested capital (ROIC) is 3.66%.

Return on Equity (ROE)	5.88%
Return on Assets (ROA)	2.29%
Return on Invested Capital (ROIC)	3.66%
Return on Capital Employed (ROCE)	5.69%
Revenue Per Employee	5.24M
Profits Per Employee	61,807
Employee Count	300,000
Asset Turnover	1.50
Inventory Turnover	19.88

Taxes

In the past 12 months, CVS Health has paid 7.10 billion in taxes.

Income Tax	7.10B
Effective Tax Rate	30.89%

Stock Price Statistics

The stock price has increased by +29.79% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+29.79%
50-Day Moving Average	69.12
200-Day Moving Average	63.47
Relative Strength Index (RSI)	87.80
Average Volume (20 Days)	34

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.11

Income Statement

In the last 12 months, CVS Health had revenue of PEN 1.36 trillion and earned 16.04 billion in profits. Earnings per share was 12.71.

Revenue	1.36T
Gross Profit	181.00B
Operating Income	33.06B
Pretax Income	22.99B
Net Income	16.04B
EBITDA	49.46B
EBIT	33.06B
Earnings Per Share (EPS)	12.71

Balance Sheet

The company has 50.17 billion in cash and 292.83 billion in debt, giving a net cash position of -242.66 billion.

Cash & Cash Equivalents	50.17B
Total Debt	292.83B
Net Cash	-242.66B
Net Cash Per Share	n/a
Equity (Book Value)	274.52B
Book Value Per Share	216.18
Working Capital	-65.53B

Cash Flow

In the last 12 months, operating cash flow was 26.79 billion and capital expenditures -9.87 billion, giving a free cash flow of 16.92 billion.

Operating Cash Flow	26.79B
Capital Expenditures	-9.87B
Free Cash Flow	16.92B
FCF Per Share	n/a

Margins

Gross margin is 13.30%, with operating and profit margins of 2.43% and 1.18%.

Gross Margin	13.30%
Operating Margin	2.43%
Pretax Margin	1.69%
Profit Margin	1.18%
EBITDA Margin	3.64%
EBIT Margin	2.43%
FCF Margin	1.24%

Dividends & Yields

This stock pays an annual dividend of 9.79, which amounts to a dividend yield of 13.11%.

Dividend Per Share	9.79
Dividend Yield	13.11%
Dividend Growth (YoY)	-0.01%
Years of Dividend Growth	5
Payout Ratio	74.62%
Buyback Yield	1.02%
Shareholder Yield	14.13%
Earnings Yield	4.84%
FCF Yield	5.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CVS Health has an Altman Z-Score of 2.12 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.12
Piotroski F-Score	6